Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 427

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

Open access
Georgin‐Lavialle, S., Terrier, B., Guedon, A.F., Heiblig, M., Comont, T., Lazaro, E., Lacombe, V., Terriou, L., Ardois, S., Bouaziz, J.‐D., Mathian, A., Le Guenno, G., Aouba, A., Outh, R., Meyer, A., Roux‐Sauvat, M., Ebbo, M., Zhao, L.P., Bigot, A., Jamilloux, Y., Guillotin, V., Flamarion, E., Henneton, P., Vial, G., Jachiet, V., Rossignol, J., Vinzio, S., Weitten, T., Vinit, J., Deligny, C., Humbert, S., Samson, M., Magy‐Bertrand, N., Moulinet, T., Bourguiba, R., Hanslik, T., Bachmeyer, C., Sebert, M., Kostine, M., Bienvenu, B., Biscay, P., Liozon, E., Sailler, L., Chasset, F., Audemard‐Verger, A., Duroyon, E., Sarrabay, G., Borlot, F., Dieval, C., Cluzeau, T., Marianetti, P., Lobbes, H., Boursier, G., Gerfaud‐Valentin, M., Jeannel, J., Servettaz, A., Audia, S., Larue, M., Henriot, B., Faucher, B., Graveleau, J., de Sainte Marie, B., Galland, J., Bouillet, L., Arnaud, C., Ades, L., Carrat, F., Hirsch, P., Fenaux, P., Fain, O., Sujobert, P., Kosmider, O., Mekinian, A., French VEXAS group, GFEV, GFM, CEREMAIA, MINHEMON · 2022 · British Journal of Dermatology

Abstract

BACKGROUND: A new autoinflammatory syndrome related to somatic mutations of UBA1 was recently described and called VEXAS syndrome ('Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome'). OBJECTIVES: To describe clinical characteristics, laboratory findings and outcomes of VEXAS syndrome. METHODS: One hundred and sixteen patients with VEXAS syndrome were referred to a French multicentre registry between November 2020 and May 2021. The frequency and median of parameters and vital status, from diagnosis to the end of the follow-up, were recorded. RESULTS: The main clinical features of VEXAS syndrome were found to be skin lesions (83%), noninfectious fever (64%), weight loss (62%), lung involvement (50%), ocular symptoms (39%), relapsing chondritis (36%), venous thrombosis (35%), lymph nodes (34%) and arthralgia (27%). Haematological disease was present in 58 cases (50%): myelodysplastic syndrome (MDS; n = 58) and monoclonal gammopathy of unknown significance (n = 12; all patients with MGUS also have a MDS). UBA1 mutations included p.M41T (45%), p.M41V (30%), p.M41L (18%) and splice mutations (7%). After a median follow-up of 3 years, 18 patients died (15·5%; nine of infection and three due to MDS progression). Unsupervised analysis identified three clusters: cluster 1 (47%; mild-to-moderate disease); cluster 2 (16%; underlying MDS and higher mortality rates); and cluster 3 (37%; constitutional manifestations, higher C-reactive protein levels and less frequent chondritis). The 5-year probability of survival was 84·2% in cluster 1, 50·5% in cluster 2 and 89·6% in cluster 3. The UBA1 p.Met41Leu mutation was associated with a better prognosis. CONCLUSIONS: VEXAS syndrome has a large spectrum of organ manifestations and shows different clinical and prognostic profiles. It also raises a potential impact of the identified UBA1 mutation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjd.20805

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 427

Metadata

Authors
Georgin‐Lavialle, S., Terrier, B., Guedon, A. F., Heiblig, M., Comont, T., Lazaro, E., Lacombe, V., Terriou, L., Ardois, S., Bouaziz, J. ‐., Mathian, A., Le Guenno, G., Aouba, A., Outh, R., Meyer, A., Roux‐Sauvat, M., Ebbo, M., Zhao, L. P., Bigot, A., Jamilloux, Y., Guillotin, V., Flamarion, E., Henneton, P., Vial, G., Jachiet, V., Rossignol, J., Vinzio, S., Weitten, T., Vinit, J., Deligny, C., Humbert, S., Samson, M., Magy‐Bertrand, N., Moulinet, T., Bourguiba, R., Hanslik, T., Bachmeyer, C., Sebert, M., Kostine, M., Bienvenu, B., Biscay, P., Liozon, E., Sailler, L., Chasset, F., Audemard‐Verger, A., Duroyon, E., Sarrabay, G., Borlot, F., Dieval, C., Cluzeau, T., Marianetti, P., Lobbes, H., Boursier, G., Gerfaud‐Valentin, M., Jeannel, J., Servettaz, A., Audia, S., Larue, M., Henriot, B., Faucher, B., Graveleau, J., de Sainte Marie, B., Galland, J., Bouillet, L., Arnaud, C., Ades, L., Carrat, F., Hirsch, P., Fenaux, P., Fain, O., Sujobert, P., Kosmider, O., Mekinian, A., French VEXAS group, & GFEV, G.
Venue
British Journal of Dermatology
Published
2021-11-28
Volume
186
Issue
3
Pages
564-574
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W3206162992
Cited by
427
References
10
FWCI
19.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*. https://app.cochat.ai/papers/10.1111/bjd.20805
The paper
Georgin‐Lavialle, S., Terrier, B., Guedon, A. F., Heiblig, M., Comont, T., Lazaro, E., Lacombe, V., Terriou, L., Ardois, S., Bouaziz, J. ‐., Mathian, A., Le Guenno, G., Aouba, A., Outh, R., Meyer, A., Roux‐Sauvat, M., Ebbo, M., Zhao, L. P., Bigot, A., . . . GFEV, G. (2022). Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*. British Journal of Dermatology. https://doi.org/10.1111/bjd.20805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.